S Onodera, H Aoyama, N Katoh, H Taguchi… - Japanese journal of …, 2011 - FPCR Results The 5-year overall survival was 95.7 (95% confidence interval: 87.3–100)% after initial treatment and 96.2 (88.8–100)% after fractionated stereotactic radiotherapy. The 5-year overall survival and local control rate of patients who received fractionated stereotactic ... Cited by 1 - Related articles - All 5 versions
H Stiebel-Kalish, E Reich, L Gal… - International Journal of …, 2011 - Elsevier Meningiomas threatening the anterior visual pathways (AVPs) and not amenable for surgery are currently treated with multisession stereotactic radiotherapy. Stereotactic radiotherapy is available with a number of devices. The most ubiquitous include the gamma knife, ... Related articles - All 3 versions
C Kopp, M Theodorou, N Poullos, V Jacob… - International Journal of …, 2011 - Elsevier Mean tumor size of all 16 pituitary adenomas before treatment was 7.4 mL (3.3–18.9 mL). We found shrinkage of the treated pituitary adenoma in all patients. Within a median follow-up of 63 months (28–100 months) an absolute mean volume reduction of 3.8 mL (0.9–12.4 mL) ... Related articles - All 3 versions
N Kanesaka, R Mikami, H Nakayama… - International Journal of …, 2011 - Elsevier The median follow-up period was 52 months (range, 4–117 months). Of the 17 patients, 3 experienced recurrence 4 to 71 months after FSRT. The 3-year local control rate was 82.4%. One patient died of thyroid cancer, and the 3-year survival rate was 94.1%. Eight patients had improved ... Related articles - All 3 versions
F Paulsen, S Doerr, H Wilhelm, G Becker… - International Journal of …, 2011 - Elsevier Median time to last clinical, radiographic, and ophthalmologic follow up was 30.2 months (n = 113), 42.7 months (n = 108), and 53.7 months (n = 91), respectively. Regression of the tumor was observed in 5 eyes and progression in 4 eyes, whereas 104 remained stable. Visual ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
